Meet the Team
.png)
Inventor and Scientific Advisor
Prof. Varda Shoshan-Barmatz's research forms the foundation of X-tosis technology, focusing on mitochondrial dysfunction and metabolic disorders. It centers on VDAC1, a key protein involved in energy regulation and apoptosis. Her work has paved the way for innovative therapeutic strategies targeting cancer, Alzheimer’s, cardiovascular disease, and type 2 diabetes, establishing X-tosis as a promising approach in these fields.
-removebg-preview.jpg)
Chief Executive Officer
Erin Henderson
Erin has more than 25 years of experience in executive roles, including Chief Business Officer at Onconetix, Inc., and founder/CEO of The Aetos Group. She possesses extensive expertise in strategic planning, business development, and investor relations management.
-removebg-preview.jpg)
Chief Scientific Officer
Yotam Nisemblat
My background: Yotam has over 15 years of experience in drug development, with expertise in Alzheimer's disease. He served as the CEO of ProteKt Therapeutics and Director of Research Collaboratoins at Minovia Therapeutics. He is experienced in preclinical and early-stage clinical development.
About Us
Bringing the solution we need
Our mission is to revolutionize the treatment of Alzheimer's, Parkinson's, and other neurodegenerative diseases by halting neurodegeneration and improving the quality of life for patients around the globe.
